Cargando…
Pharmacogenomics of chemotherapeutic susceptibility and toxicity
The goal of personalized medicine is to tailor a patient's treatment strategy on the basis of his or her unique genetic make-up. The field of oncology is beginning to incorporate many of the strategies of personalized medicine, especially within the realm of pharmacogenomics, which is the study...
Autores principales: | Moen, Erika L, Godley, Lucy A, Zhang, Wei, Dolan, M Eileen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580423/ https://www.ncbi.nlm.nih.gov/pubmed/23199206 http://dx.doi.org/10.1186/gm391 |
Ejemplares similares
-
Integrating epigenomics into pharmacogenomic studies
por: Zhang, Wei, et al.
Publicado: (2008) -
The HapMap Resource is Providing New Insights into Ourselves and its Application to Pharmacogenomics
por: Zhang, Wei, et al.
Publicado: (2008) -
Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016) -
Copy number polymorphisms and anticancer pharmacogenomics
por: Gamazon, Eric R, et al.
Publicado: (2011) -
Alterations of 5-Hydroxymethylcytosine in Human Cancers
por: Mariani, Christopher J., et al.
Publicado: (2013)